<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003245065
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1999
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ADOL SINUS 325MG-30MG CAPLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PARACETAMOL,PSEUDOEPHEDRINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        325,30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        10.90
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02BE51
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>adol SINUS</strong> is used for the relief of nasal congestion when combined with fever and/or pain such as sore throat, sinus pain or headache in the common cold or flu. The medicine contains two active ingredients. Paracetamol is a painkiller and reduces your temperature when you have a fever. Pseudoephedrine hydrochloride is a decongestant which unblocks your nose and sinuses helping you breathe more easily without drowsiness.</p><p style="text-align:justify">You must talk to a doctor if you do not feel better or if you feel worse after 5 days</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take <strong>adol SINUS</strong>:</p><p>&middot;&nbsp;&nbsp; If you are allergic to paracetamol, pseudoephedrine hydrochloride or any of the other ingredients in this product (listed in Section 6).</p><p>&middot;&nbsp;&nbsp; if you are taking other sympathomimetics (such as decongestants, tricyclic antidepressants).&nbsp;</p><p>&middot;&nbsp;&nbsp; If you have high blood pressure, overactive thyroid gland, enlarged prostate, heart problems, glaucoma (excessive pressure inside your eyes).</p><p>&middot;&nbsp;&nbsp; If you have kidney failure, unless your doctor tells you to.</p><p>&middot;&nbsp;&nbsp; If you have taken monoamine oxidase inhibitors (MAOIs), usually prescribed for depression, in the last two weeks.</p><p>&middot;&nbsp;&nbsp; If you are taking the drug moclobemide for depression, beta-blockers for high blood pressure, the oxazolidinone class of antibiotics ( e.g. furazolidone or linezolid), appetite suppressants, or stimulant drugs&nbsp; called amphetamines (sometimes used to treat attention deficit disorders or excessive sleepiness).</p><p>&middot;&nbsp;&nbsp; If you develop a feverish generalised erythema associated with pustules, stop taking <strong>adol SINUS</strong> and contact your doctor or seek medical attention immediately. See section 4.</p><p>&middot;&nbsp;&nbsp; If you are under 12 years.</p><p><strong>Do not take</strong> anything else containing paracetamol while taking this medicine.</p><p><strong>Warnings and precautions</strong></p><p>Contains paracetamol.</p><p>Do not take more than the recommended dose as it may cause serious harm to your liver. Do not use this medicine if you are taking any other medicines which may contain paracetamol including prescription or non-prescription medicines to treat pain, fever, symptoms of cold and flu.</p><p>Do not take with other flu, cold or decongestant product</p><p>Sudden abdominal pain or rectal bleeding may occur with <strong>adol SINUS</strong>, due to inflammation of the colon (ischemic colitis). If you develop these gastro-intestinal symptoms, stop taking <strong>adol SINUS </strong>and contact your doctor or seek medical attention immediately. See section 4.</p><p>Reduction of blood flow to your optic nerve may occur with <strong>adol SINUS</strong>. If you develop sudden loss of vision, stop taking <strong>adol SINUS</strong> and contact your doctor or seek medical attention immediately. See section 4.</p><p>As with other CNS stimulants, pseudoephedrine, has the potential to be abused and large doses of pseudoephedrine can be toxic. Continuous use may lead to taking more <strong>adol SINUS</strong> caplets than the recommended dose to get the desired effect, resulting in an increased risk of overdosing.</p><p><strong>Talk to your doctor or pharmacist before taking adol SINUS:</strong></p><p>&middot;&nbsp;&nbsp; If you are due to undergo general anaesthesia, or have liver disease, including alcoholic liver disease, or kidney problems, diabetes (too much sugar in your blood), psychosis (severe mental health problems in which the person loses contact with reality and is unable to think and judge clearly), irregular heart beat or phaeochromocytoma (a tumour near the kidney). You may need to avoid using this product altogether or limit the amount of paracetamol that you take.</p><p>&middot;&nbsp;&nbsp; if you suffer from glutathione depletion due to metabolic deficiencies.</p><p>&middot;&nbsp;&nbsp; If you are more than 60 years old, as there is increased possibility of unwanted effects.</p><p>&middot;&nbsp;&nbsp; If you are taking medicines that affect your liver.</p><p>Check with your doctor before use if you have liver or kidney problems, are underweight (&lt;50kg), become malnourished or regularly drink alcohol, as this may increase your risk of liver damage. You may need to reduce the amount of paracetamol that you take or avoid using this product altogether.</p><p><strong>Other medicines and adol SINUS</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines particularly:</p><p>&middot;&nbsp;&nbsp; anticoagulants (used to thin the blood, e.g. warfarin);</p><p>&middot;&nbsp;&nbsp; metoclopramide or domperidone (for nausea [feeling sick] or vomiting [being sick]);</p><p>&middot;&nbsp;&nbsp; cholestyramine (to lower blood cholesterol);</p><p>&middot;&nbsp;&nbsp; medicines for high blood pressure; or vasoconstrictor agents such as ergot derivates (sometimes prescribed for migraine or hyperprolactinemia)</p><p>&middot;&nbsp;&nbsp; medicines for depression (tricyclic antidepressants e.g. amitriptyline);</p><p>&middot;&nbsp;&nbsp; sodium bicarbonate (used to treat indigestion and certain kidney conditions).</p><p>&middot;&nbsp;&nbsp; In case of surgery, it is advisable to stop treatment at least 24 hours before.</p><p>&middot;&nbsp;&nbsp; The pseudoephedrine content in this product may induce a positive reaction during antidoping control tests.</p><p><strong><u>Please inform your doctor or pharmacist if you are taking:</u></strong></p><p>-&nbsp; <strong>Flucloxacillin</strong> (antibiotic), due to a serious risk of blood and fluid abnormality (high anion gap metabolic acidosis) that must have urgent treatment and which may occur particularly in case of severe renal impairment, sepsis (when bacteria and their toxins circulate in the blood leading to organ damage), malnutrition, chronic alcoholism, and if the maximum daily doses of paracetamol are used.</p><p>-&nbsp; <strong>Phenytoin</strong> may reduce the effect of paracetamol on relieving pain and fever and may increase the formation of the toxic N-acetyl-p-benzoquinone imine (NAPQI) metabolite of paracetamol which may lead to increased risk of liver toxicity.</p><p><strong>Pregnancy and breastfeeding</strong></p><p><strong>adol SINUS</strong> is not recommended during pregnancy or whilst breastfeeding. If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>Driving and using machines</strong></p><p>This product can cause dizziness as a side effect which could affect your ability to drive or use machines. Do not drive or operate machinery if affected.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take <strong>adol SINUS</strong> exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>The recommended dose is:</p><p>&middot;&nbsp;&nbsp; <strong>Adults (including the elderly): </strong></p><p>Swallow 2 caplets up to 3 times daily.</p><p>Leave at least 4 hours between doses.</p><p>Do not take more than 6 caplets in 24 hours.</p><p>&middot;&nbsp;&nbsp; <strong>Adolescents aged 16 to 18 years:</strong></p><p>Give 1 to 2 caplets up to 3 times daily.</p><p>Leave at least 4 hours between doses.</p><p>Do not give more than 6 caplets in 24 hours.</p><p>&middot;&nbsp;&nbsp; <strong>Adolescents aged 12 to 15 years:</strong></p><p>Give 1 caplet up to 3 times daily.</p><p>Leave at least 4 hours between doses.</p><p>Do not give more than 3 caplets in 24 hours.</p><p>Always use the lowest effective dose to relieve your symptoms for the shortest period of time necessary.</p><p><strong>Do not take</strong> more frequently than every 4 hours.</p><p><strong>Do not take</strong> for more than 5 days.</p><p><strong>Do not take </strong>more than the recommended dose.</p><p><strong>If you take more adol SINUS than you should</strong></p><p>Talk to your doctor immediately if you take too much of this medicine, even if you feel well. This is because too much paracetamol may cause delayed, serious and irreversible liver damage.</p><p>If your symptoms persist, see your doctor or pharmacist.</p><p>If you have any further questions on the use of this medicine ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines <strong>adol SINUS </strong>can have side effects, but not everybody gets them:</p><p><strong>Stop taking this medicine and seek immediate medical attention if you experience:</strong></p><p>&middot;&nbsp;&nbsp; Sudden severe headache.</p><p>&middot;&nbsp;&nbsp; Inflammation of the colon due to insufficient blood supply (ischemic colitis)</p><p>&middot;&nbsp;&nbsp; Breathing problems, especially if you have experienced a similar reaction with aspirin or non-steroidal anti-inflammatories.</p><p>&middot;&nbsp;&nbsp; Skin rash or peeling, or mouth ulcers.</p><p>&middot;&nbsp;&nbsp; Unexplained bruising or bleeding, or infections such as sore throat - this may be a sign of very rare changes in the blood.</p><p>&middot;&nbsp;&nbsp; Allergic reactions such as skin rash or itching, sometimes with breathing problems (or a hissing sound when you breathe) or swelling of the mouth, lips, tongue, throat or face.</p><p>&middot;&nbsp;&nbsp; Difficulty in passing urine. This is more likely to occur in men if you have an enlarged prostate gland.</p><p>&middot;&nbsp;&nbsp; Sudden onset of fever, reddening of the skin, or many small pustules (possible symptoms of Acute Generalized Exanthematous Pustulosis - AGEP) may occur within the first 2 days of treatment with <strong>adol SINUS</strong>. See section 2.</p><p>&middot;&nbsp;&nbsp; Reduced blood flow to the optic nerve (Ischaemic optic neuropathy). The frequency is &ldquo;not known&rdquo;. See section 2.</p><p><strong>Other side effects: </strong></p><p><strong>The following side effects may occur. Tell your doctor or pharmacist if you get them.</strong></p><p>&middot;&nbsp;&nbsp; Nausea [feeling sick], vomiting [being sick], dry mouth, sleep disturbance, nervousness and dizziness. These are common side effects, (may affect up to 1 in every 10 patients treated).</p><p>&middot;&nbsp;&nbsp; Rapid or irregular heart rate, agitation and restlessness. These are uncommon side effects (may affect up to 1 in every 100 patients treated).</p><p>&middot;&nbsp;&nbsp; High blood pressure, palpitations and hallucinations (particularly in children) are rare side effects, (may affect up to 1 in every 1,000 patients treated).</p><p>&middot;&nbsp;&nbsp; Anxiety, headache and tremor [shivering]</p><p>&middot;&nbsp;&nbsp; This product may have side effects that you would not notice yourself. These include changes in some liver test results.</p><p><strong><u>Reporting of side effects </u></strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:</p><p>&middot;&nbsp;&nbsp; <strong>Saudi Arabia:</strong></p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</strong></p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp; - Fax: </strong>+966-11-205-7662</p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp; - SFDA Call Centre: </strong>19999,<strong> </strong></p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp; - E-mail: </strong>npc.drug@sfda.gov.sa</p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp; - Website: </strong>https://ade.sfda.gov.sa</p><p>&middot;&nbsp;&nbsp; <strong>Other GCC States: </strong></p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp; </strong>Please contact the relevant competent authority.</p><p>By reporting side effects, you can help provide more information on the safety of this medicine</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:9.0pt; margin-right:0cm; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]--></p><p>&ndash;&nbsp;&nbsp; Keep this medicine out of the reach and sight of children.</p><p>&ndash;&nbsp;&nbsp; Store below 30&ordm;C, in a dry place, in the original container.</p><p>&ndash;&nbsp;&nbsp; Do not take <strong>adol SINUS</strong> after the expiry date which is stated on the blister and carton. The expiry date refers to the last day of that month.&nbsp;</p><p>&ndash;&nbsp;&nbsp; Do not take <strong>adol SINUS</strong> if you notice any visible sign of deterioration.</p><p style="margin-left:9.0pt; margin-right:0cm; text-align:justify; text-indent:-9.0pt">&nbsp; &nbsp;&ndash;&nbsp;&nbsp;&nbsp;Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substances are paracetamol and pseudoephedrine.</p><p>Each caplet contains: Paracetamol 325mg and Pseudoephedrine HCl 30mg.</p><p>Other ingredients: Maize starch, povidone, microcrystalline cellulose, cellulose powder, primojel, stearic acid fine powder, talc fine powder, magnesium stearate, hypromellose, polyethylene glycol, titanium dioxide, FD&amp;C blue No. 1 lake, D&amp;C yellow No. 10 lake and opadry-OY-S 29019 clear.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                adol SINUS are available in packs of 24 caplets each.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
30/11/2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يستخدم <strong>أدول ساينس</strong> لتخفيف حالات احتقان الأنف التي تكون مصحوبة بحمى و/أو ألم على سبيل المثال التهاب الحلق، وألم الجيوب الأنفية أو الصداع في نزلات البرد أو الإنفلونزا. يحتوي هذا الدواء على مادتين فعالتين. الباراسيتامول و هو مسكن للألم، ويقلل من درجة الحرارة عندما يكون لديك حمى. السودوإفيدرين هيدروكلوريد&nbsp; و هو مضاد للاحتقان يزيل انسداد الأنف والجيوب الأنفية ويساعدك على التنفس بسهولة أكثر دون الشعور بالنعاس. قم بالتحدث إلى طبيبك المعالج، في حال عدم الشعور بالتحسن أو في حال تفاقم حالتك الصحية بعد مرور&nbsp;&nbsp;5 أيام من استعمال هذا الدواء</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">●&nbsp;&nbsp; إذا كنت تعاني من الحساسية تجاه الباراسيتامول، السودوإفيدرين هيدروكلوريد أو تجاه أياً من المكونات الأخرى في هذا الدواء (المذكورة في<br />البند رقم 6).</p><p dir="RTL">●&nbsp;&nbsp; إذا كنت تتناول أياً من الأدوية المحفزة للسمبثاوي الأخرى (على سبيل المثال مزيلات الاحتقان، مضادات الاكتئاب ثلاثية الحلقات)</p><p dir="RTL">●&nbsp;&nbsp; إذا كنت تعاني من ارتفاع في ضغط الدم، فرط نشاط الغدة الدرقية، تضخم البروستاتا، مشاكل في القلب والجلوكوما (ضغط مفرط داخل<br />العينين).</p><p dir="RTL">●&nbsp;&nbsp; إذا كنت تعاني من قصور في الكلى، إلا في حال أخبرك طبيبك المعالج خلاف ذلك.</p><p dir="RTL">●&nbsp;&nbsp; إذا كنت قد تناولت خلال الأسبوعين الأخيرين&nbsp; مثبطات إنزيم الأكسدة أحادي الأمين، التي توصف عادةً لعلاج الاكتئاب.</p><p dir="RTL">●&nbsp;&nbsp; إذا كنت تتناول دواء موكلوبيمايد لعلاج الاكتئاب، غالقات مستقبلات بيتا لعلاج ارتفاع ضغط الدم، المضادات الحيوية من مجموعة<br />الأوكسازوليدينون (عل سبيل المثال فورازوليدون أو لينزوليد)، مثبطات الشهية، أو أدوية منشطة من مجموعة الأمفيتامين (تستخدم في بعض الأحيان لعلاج اضطرابات نقص الانتباه أو النعاس المفرط).</p><p dir="RTL">●&nbsp;&nbsp; يرجى منك التوقف عن تناول <strong>أدول ساينس</strong> و التواصل مع طبيبك المعالج على الفور للحصول على العناية الطبية اللازمة في حال إصابتك<br />بالحمامى المعممة المصحوبة بحدوث حمى و بثور. انظر البند رقم 4.</p><p dir="RTL">●&nbsp;&nbsp; إذا كنت بعمر أقل من 12 سنة.</p><p dir="RTL"><strong>يجب عليك عدم تناول </strong>هذا الدواء بالتزامن مع أياً من الأدوية الأخرى التي تحتوي على الباراسيتامول.</p><p dir="RTL"><strong>تحذيرات و احتياطات</strong></p><p dir="RTL">يحتوي على الباراسيتامول</p><p dir="RTL">يرجى عدم تناول أكثر من الجرعة الموصى بها، نظراً لخطر الإصابة بأضرار خطيرة في الكبد.</p><p dir="RTL">يرجى عدم استعمال هذا الدواء إذا كنت تتناول أية أدوية أخرى تحتوي على الباراسيتامول بما في ذلك الأدوية التي تعطى بموجب وصفة طبية أو بدون وصفة طبية لعلاج الألم والحمى وأعراض البرد والإنفلونزا.</p><p dir="RTL">يجب عليك عدم تناول<strong> </strong>هذا الدواء بالتزامن مع أي أدوية أخرى تستخدم لعلاج الإنفلونزا، نزلات البرد أو الاحتقان.</p><p dir="RTL">قد يحدث ألم مفاجئ في البطن أو نزيف من المستقيم أثناء استخدام <strong>أدول ساينس</strong>، وذلك بسبب حدوث التهاب في القولون (التهاب القولون الإقفاري). يرجى منك التوقف عن تناول <strong>أدول ساينس</strong> والاتصال بطبيبك المعالج أو طلب العناية الطبية على الفور،&nbsp; في حال ظهور هذه الأعراض المعدية المعوية. انظر بند رقم 4.</p><p dir="RTL">&nbsp;قد يحدث انخفاض في تدفق الدم إلى العصب البصري أثناء استخدام&nbsp; <strong>أدول ساينس</strong>. يرجى منك التوقف عن تناول <strong>أدول ساينس</strong> والاتصال بطبيبك المعالج أو طلب العناية الطبية على الفور، في حال أصبت بفقدان مفاجئ في الرؤية. انظر بند رقم 4.</p><p dir="RTL">كما هو الحال مع المحفزات الأخرى للجهاز العصبي المركزي، فإن تناول سودوإفيدرين قد يؤدي إلى سوء الاستخدام، حيث من الممكن أن يؤدي تناول جرعات كبيرة من سودوإفيدرين إلى حدوث تسمم. قد يؤدي الاستمرار في تناول هذا الدواء إلى تناول المزيد من أقراص <strong>أدول ساينس</strong> بصورة أكبر من الجرعة الموصى بها للحصول على التأثير المطلوب، مما يؤدي إلى زيادة خطر حدوث جرعة مفرطة.</p><p dir="RTL"><strong>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول</strong> <strong>أدول ساينس:</strong></p><p dir="RTL">&middot;&nbsp; إذا كان من المقرر أن تخضع للتخدير العام، أو إذا كنت تعاني من اضطراب في الكبد بما في ذلك اضطرابات الكبد الناجمة عن تناول الكحول أو مشاكل في الكلى، داء السكري (ارتفاع مستوى السكر في الدم)، الذهان&nbsp; (اضطرابات شديدة في الصحة العقلية حيث يفقد فيها الشخص الاتصال بالواقع ولا يستطيع التفكير و إصدار الأحكام&nbsp; بوضوح)، عدم انتظام ضربات القلب أو ورم القواتم (ورم قرب الكلى).&nbsp; قد تحتاج إلى تجنب استخدام هذا الدواء تمامًا أو تقليل&nbsp; كمية الباراسيتامول التي تتناولها.</p><p dir="RTL">&middot;&nbsp; إذا كنت تعاني من حالات استنفاذ الجلوتاثيون الناجم عن النقص الأيضي.</p><p dir="RTL">&middot;&nbsp; إذا كان عمرك أكثر من 06 عامًا ، فهناك احتمالية كبيرة لحدوث تأثيرات غير مرغوب بها.</p><p dir="RTL">&middot;&nbsp; إذا كنت تتناول أدوية تؤثر على الكبد.</p><p dir="RTL">يرجى منك استشارة طبيبك المعالج قبل استخدام هذا الدواء إذا كنت تعاني من مشاكل في الكبد أو الكلى، تعاني من نقص في الوزن (أقل من 50 كلغم)، سوء التغذية أو كنت تتناول الكحول بانتظام ، و ذلك لخطر حدوث تلف في الكبد. قد تحتاج إلى تقليل كمية الباراسيتامول التي تتناولها أو تجنب استخدام هذا الدواء تمامًا.</p><p dir="RTL"><strong>تناول الأدوية الأخرى بالتزامن مع أدول ساينس</strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه في حال كنت تتناول، تناولت مؤخراً أو قد تتناول أية أدوية أخرى وبصفة خاصة:</p><p dir="RTL">●&nbsp;&nbsp; مضادات التخثر (أدوية تستخدم لترقيق الدم، مثل الوارفارين)؛</p><p dir="RTL">●&nbsp;&nbsp; ميتوكلوبراميد أو دومبيريدون (لعلاج الغثيان [الشعور بالأعياء] أو تقيؤ [توعك])</p><p dir="RTL">●&nbsp;&nbsp; الكوليستيرامين (لخفض نسبة الكوليسترول في الدم)؛</p><p dir="RTL">●&nbsp;&nbsp; الأدوية التي تستخدم&nbsp; لعلاج ارتفاع ضغط الدم؛ أو الأدوية التي تعمل على تضيق الأوعية الدموية مثل مشتقات الإرغوت (يتم وصفها أحيانًا<br />لعلاج الصداع النصفي أو فرط البرولاكتين الدم)</p><p dir="RTL">●&nbsp;&nbsp; الأدوية التي تستخدم لعلاج الاكتئاب (مضادات الاكتئاب ثلاثية الحلقات على سبيل المثال أميتريبتيلين)؛</p><p dir="RTL">●&nbsp;&nbsp; بيكربونات الصوديوم (تستخدم لعلاج عسر الهضم وحالات معينة من أمراض الكلى).</p><p dir="RTL">● &nbsp; في حال كان من المقرر أن تخضع للجراحة، فإنه ينصح بالتوقف عن استعمال هذا الدواء&nbsp; قبل 42 ساعة على الأقل.<br />● &nbsp; قد يسبب السودوإيفيدرين في هذا الدواء في حدوث تفاعلات إيجابية أثناء اجراء اختبارات الكشف عن المنشطات.</p><p dir="RTL"><strong>يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول:</strong></p><p dir="RTL">&minus; &nbsp; <strong>فلوكلوكساسيلين</strong> (مضاد حيوي)، نظراً لخطر حدوث نتائج غير طبيعية في الدم والسوائل (الحماض الأيضي ذو الفجوة الأنيونية المرتفعة)<br />الذي يجب أن يخضع للعلاج العاجل والذي قد يحدث بشكل خاص في حالات القصور الكلوي الشديد، والإنتان (عندما تنتشر البكتيريا وسمومها في الدم مما يؤدي إلى تلف الأعضاء)، سوء التغذية، إدمان الكحول المزمن، وفي حال تلقي الجرعات اليومية القصوى من الباراسيتامول.</p><p dir="RTL">&minus; &nbsp; <strong>الفينيتوين</strong> و الذي قد يقلل من قدرة الباراسيتامول على تخفيف الألم والحمى كما قد يزيد من تكوين مستقلب الباراسيتامول السام (إن - أسيتيل<br />- بي- بنزوكينون إمين) مما قد يؤدي إلى زيادة خطر حدوث تسمم الكبد.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية: </strong></p><p dir="RTL">لا ينصح باستخدام <strong>أدول ساينس</strong> أثناء فترة الحمل أو الرضاعة الطبيعية. يرجى منك التواصل مع طبيبك المعالج أو الصيدلي الذي تتعاملين معه للحصول على المشورة الطبية، إذا كنت حاملاً أو ترضعين طفلك رضاعة طبيعية، تعتقدين أنك حامل أو تخططين لإنجاب طفل.</p><p dir="RTL"><strong>القيادة واستخدام الآلات </strong></p><p dir="RTL">قد يتسبب هذا الدواء في حدوث تأثيرات جانبية مثل الدوار مما&nbsp; قد يؤثر على قدرتك على القيادة أو استخدام الآلات. يرجى منك عدم القيادة أو استخدام الآلات إذا تعرضت لذلك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك دائماً تناول <strong>أدول ساينس</strong> بدقة كما هو موضح في هذه النشرة أو وفقاً لتعليمات طبيبك المعالج أو الصيدلي الذي تتعامل معه. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه مالم تكن متأكداً من كيفية تناول هذا الدواء.</p><p dir="RTL"><strong>●&nbsp;&nbsp; البالغون (بما في ذلك فئة كبار السن): </strong></p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; قم بابتلاع قرصين حتى 3 مرات يومياً.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; يجب ترك فترة زمنية فاصلة 4 ساعات ما بين الجرعات.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم تناول أكثر من 6 أقراص خلال 24 ساعة.</p><p dir="RTL"><strong>●&nbsp;&nbsp; المراهقون بعمر يتراوح من 16إلى 18سنة:</strong></p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; قم بإعطاء قرص واحد إلى قرصين حتى 3 مرات يومياً.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; يجب ترك فترة زمنية فاصلة 4 ساعات ما بين الجرعات.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم إعطاء أكثر من 6 أقراص خلال 24 ساعة.</p><p dir="RTL"><strong>●&nbsp;&nbsp; المراهقون بعمر يتراوح من 12إلى 15سنة:</strong></p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; قم بإعطاء قرص واحد حتى 3 مرات يومياً.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; يجب ترك فترة زمنية فاصلة 4 ساعات ما بين الجرعات.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم إعطاء أكثر من 3 أقراص خلال 24 ساعة.</p><p dir="RTL">يجب عليك دائما استخدام أقل جرعة فعالة لتخفيف الأعراض خلال أقصر فترة زمنية.</p><p dir="RTL"><strong>يجب عليك عدم تناول</strong> هذا الدواء أكثر من&nbsp; كل 4 ساعات&lrm;.</p><p dir="RTL"><strong>يجب عليك عدم تناول </strong>هذا الدواء<strong> </strong>لمدة زمنية تتجاوز عن 5 أيام.</p><p dir="RTL"><strong>يجب عليك عدم </strong>تجاوز مقدار الجرعة الموصى بها في هذه النشرة . يرجى منك التحدث إلى طبيبك المعالج في حال لم تتحسن حالتك الصحية</p><p dir="RTL"><strong>إذا تناولت العديد من أقراص أدول ساينس</strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج&nbsp; على الفور في حال تناول جرعة مفرطة، حتى و إن كنت تشعر أنك بصحة جيدة، وذلك لأن تناول جرعة عالية من الباراسيتامول قد يؤدي إلى حدوث تلف كبدي خطير و متأخر.</p><p dir="RTL">يرجى منك مراجعة طبيبك المعالج أو الصيدلي الذي تتعامل معه، في حال استمرار الأعراض لديك.</p><p dir="RTL">يرجى منك مراجعة طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا كان لديك أي اسئلة حول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع جميع الأدوية، قد يسبب<strong> أدول ساينس</strong> في حدوث تأثيرات جانبية، بالرغم من أنها قد لا تحدث لكل شخص.</p><p dir="RTL"><strong>يرجى منك التوقف عن تناول هذا الدواء وطلب الرعاية الطبية على الفور إذا عانيت مما يلي:</strong></p><p dir="RTL">●&nbsp;&nbsp; صداع شديد مفاجئ.</p><p dir="RTL">●&nbsp;&nbsp; التهاب في القولون بسبب نقص إمدادات الدم (التهاب القولون الإقفاري)</p><p dir="RTL">●&nbsp;&nbsp; مشاكل في التنفس، وبصفة خاصة إذا كنت قد تعرضت لتفاعل مشابه عند تناول الأسبرين أو الأدوية غير الستيرويدية المضادة للالتهابات.</p><p dir="RTL">●&nbsp;&nbsp; طفح جلدي أو تقشر الجلد، أو تقرحات فموية.</p><p dir="RTL">●&nbsp;&nbsp; ظهور كدمات أو حدوث نزيف بصورة غير مبررة، أو عدوى على سبيل المثال التهاب الحلق والتي قد تكون علامة لتغيرات نادرة جداً في<br />الدم.</p><p dir="RTL">●&nbsp;&nbsp; تفاعلات تحسسية على سبيل المثال طفح جلدي أو حكة، وفي بعض الأحيان يصاحبها مشاكل في التنفس (أو صوت يشبه الصفير أثناء<br />التنفس) أو تورم في الشفتين، اللسان، الحلق أو الوجه.</p><p dir="RTL">●&nbsp;&nbsp; صعوبة في إدرار البول. و يحدث هذا بصورة أكبر إذا كنت تعاني من تضخم في غدة البروستاتا.</p><p dir="RTL">● &nbsp; ظهور حمى بصورة مفاجئة ، احمرار الجلد، أو ظهور العديد من البثور الصغيرة ( و هي الأعراض المحتملة لحدوث بثار طفحي حاد معمم)<br />قد تحدث هذه الأعراض خلال أول يومين من تلقي العلاج بـاستخدام <strong>&nbsp;أدول ساينس</strong>. انظر البند رقم 2.</p><p dir="RTL">● &nbsp; انخفاض في تدفق الدم إلى العصب البصري (الاعتلال العصبي البصري الناجم عن نقص التروية)، معدل تكرار حدوث ذلك &ldquo;غير معروف&rdquo;،<br />انظر البند رقم 2.</p><p dir="RTL"><strong>التأثيرات الجانبية الأخرى </strong></p><p dir="RTL"><strong>قد تحدث التأثيرات الجانبية التالية، يرجى منك إخبار طبيبك المعالج&nbsp; أو الصيدلي الذي تتعامل معه إذا عانيت أياً منها.</strong></p><p dir="RTL">●&nbsp;&nbsp; غثيان [الشعور بالإعياء]، تقيؤ [توعك]، جفاف الفم، اضطرابات النوم، عصبية ودوخة. وهذه تأثيرات جانبية شائعة (تؤثر على ما يصل إلى<br />1 لكل 10 من المرضى الذين تلقوا العلاج).</p><p dir="RTL">●&nbsp;&nbsp; تسارع أو عدم انتظام ضربات القلب، تهيج وعدم الشعور بالراحة. وهذه تأثيرات غير شائعة (تؤثر على ما يصل إلى 1 لكل 100 من<br />المرضى الذين تلقوا العلاج)</p><p dir="RTL">●&nbsp;&nbsp; ارتفاع ضغط الدم، خفقان وهلوسة (و بصفة خاصة لدى الأطفال)، وتعد هذه التأثيرات الجانبية نادرة (تؤثر على ما يصل إلى 1 لكل 1000<br />من المرضى الذين تلقوا العلاج).</p><p dir="RTL">● &nbsp; قلق، صداع ورعشة [رجفة]</p><p dir="RTL">●&nbsp;&nbsp; قد يؤدي تناول هذا الدواء إلى حدوث تأثيرات جانبية لا يمكنك ملاحظتها من تلقاء نفسك، وتتضمن تغيرات في بعض نتائج فحوصات الكبد.<strong> </strong></p><p dir="RTL"><strong><u>للإبلاغ عن حدوث تأثيرات جانبية:</u></strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج، الصيدلي الذي تتعامل معه أو الممرض، في حال حدوث أياً من التأثيرات الجانبية بما في ذلك أية تأثيرات جانبية يحتمل حدوثها و لم يتم ذكرها في هذه النشرة.</p><p dir="RTL">كما يمكنك أيضاً الإبلاغ عن التأثيرات الجانبية مباشرة عن طريق:</p><p dir="RTL">●<strong>&nbsp;&nbsp; المملكة العربية السعودية</strong></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ الدوائي</strong></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp; - رقم الفاكس:&nbsp; </strong>&nbsp;7662-205-11-966+</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp; - مركز الاتصال الموحد:</strong> 19999</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp; - البريد الإلكتروني:&nbsp; </strong>npc.drug@sfda.gov.sa</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp; - الموقع الإلكتروني: </strong>https://ade.sfda.gov.sa</p><p dir="RTL">●<strong>&nbsp;&nbsp; دول مجلس التعاون الخليجي الأخرى:</strong></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp; </strong>&nbsp;يرجى الاتصال بالجهات المختصة ذات الصلة</p><p dir="RTL">إن تسجيل التأثيرات الجانبية يساعد في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&ndash;&nbsp;&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">&ndash;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30&ordm;&nbsp;م، في مكان جاف، في العبوة الأصلية.</p><p dir="RTL">&ndash;&nbsp;&nbsp; يجب عدم تناول <strong>أدول ساينس</strong> بعد تاريخ انتهاء الصلاحية المذكور على العبوة والشريط. يشير تاريخ الانتهاء إلى آخر يوم من الشهر<br />المذكور.</p><p dir="RTL">&ndash;&nbsp;&nbsp; يجب عدم تناول <strong>أدول ساينس</strong> إذا لاحظت وجود علامات تلف واضحة.</p><p dir="RTL">&ndash;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية<br />التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p><p dir="RTL" style="margin-right:10.8pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]--></p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي باراسيتامول وسودوإفيدرين&nbsp;</p><p dir="RTL">يحتوي كل قرص على: باراسيتامول 325 ملغم وسودوإفيدرين هيدروكلوريد 30 ملغم.</p><p dir="RTL">المواد الغير فعالة: نشا الذرة، بوفيدون، بلورات السليلوز متناهية الصغر، مسحوق السليلوز، بريموجل، مسحوق حمض الستيريك الناعم، مسحوق التلك الناعم، ستيرات المغنيسيوم، هيبروميلوز، بولي إثيلين جلايكول، ثنائي أكسيد التيتانيوم، إف دي وسي أزرق رقم 1، دي وسي أصفر رقم 10 و أوبادراي-أو واي-إس 29019 كلير.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تتوفر أقراص <strong>أدول ساينس</strong> في عبوات تحتوي كلاً منها على 24 قرصاً.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            م 30/11/2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Adol Sinus Film-coated Caplets  
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated caplet contains:
Item no.	Material Name	Scale (mg/caplet)
		
	Active ingredients: 	
1.		Paracetamol fine powder 	325.00
2.		Pseudoephedrine Hydrochloride 	30.00
		
	Inactive ingredients:	
1.		Maize starch 	93.50
2.		Povidone 	17.00
3.		Microcrystalline cellulose 	110.00
4.		Cellulose powder 	9.50
5.		Primojel 	20.00
6.		Stearic acid fine powder 	8.00
7.		Talc fine powder 	5.00
8.		Magnesium stearate 	2.00
		
	Coating materials: 	
1.		Hypromellose 	10.00
2.		Talc fine powder 	4.00
3.		Polyethylene glycol 	1.60
4.		Titanium dioxide 	2.125
5.		FD&C blue no. 1 lake 	0.053
6.		D&C yellow no. 10 lake 	0.150
7.		Opadry- OY-S 29019 clear 	0.75
8.		Purified water	q.s. 

For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated Caplets
Description: Greenish, oblong film coated caplets, matt surface, may show colour specs.
Face one: plain
Face Two: plain

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Adol Sinus</strong> is indicated in adults and adolescents aged 12 to 18 years.</p><p>Symptomatic relief of nasal congestion when combined with fever and/or pain such as, sore throat, sinus pain or headache in the common cold or influenza.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology</strong></p><p>The lowest dose necessary to achieve efficacy should be used for the shortest duration of treatment.</p><p>&nbsp;</p><p><strong><u>&nbsp;Adults, including the elderly:</u></strong></p><p>Two caplets up to three times daily as required for relief of symptoms.</p><p>The dose should not be repeated more frequently than every four hours nor should more than three doses be given in any 24 hour period.</p><p><strong>Paediatric Population</strong></p><p><strong><u>Adolescents aged 16 to 18 years old</u></strong></p><p>One to two tablets up to three times daily as required for relief of symptoms.</p><p>The dose should not be repeated more frequently than every four hours nor should more than three doses be given in any 24 hour period.</p><p><strong><u>Adolescents aged 12 to 15 years old:</u></strong></p><p>One caplet up to three times daily as required for relief of symptoms.</p><p>&nbsp;The dose should not be repeated more frequently than every four hours nor should more than three doses be given in any 24 hour period.</p><p><strong>Not to be used in children under 12 years of age (see section 4.3).</strong></p><p><strong>Patients with renal impairment</strong></p><p>Pseudoephedrine is primarily excreted renally. Pseudoephedrine should not be used by those with severe renal impairment GFR&lt;30mL/min (see section 4.3) and should be used with caution in those with moderate renal impairment GFR 30-59 mL/min (see sections 4.4 and 5.2).</p><p><strong>Patients with hepatic impairment</strong></p><p>Patients who have been diagnosed with hepatic impairment must seek medical advice before taking this medication. The restrictions related to the use of such combinations in patients with hepatic impairment are primarily a consequence of the paracetamol content of the product (see section 4.4).</p><p><strong><u>Method of administration</u></strong></p><p>For oral use.</p><p>Patients should be advised not to use this product for more than 5 days and to seek medical advice if symptoms persist.</p><p>Do not exceed the stated dose.</p><p>The tablets should be taken with water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Hypersensitivity to paracetamol, pseudoephedrine, or any of the excipients listed in section 6.1.
	Not to be used by patients taking moclobemide or monoamine oxidase inhibitors (MAOI’s) or for two weeks after stopping the MAOI drug.
	The oxazolidinone class of antibiotics (including furazolidone and linezolid) should not be taken with paracetamol/ pseudoephedrine caplets (see section 4.5).
	Not to be used by patients with the following conditions:
-	Hypertension.
-	Cardiovascular disease
-	Hyperthyroidism
-	Prostatic hypertrophy
-	Glaucoma
-	Severe renal impairment (GFR<30mL/min)
	Not to be used by patients currently receiving other sympathomimetics (such as decongestants, tricyclic antidepressants, appetite suppressants and amphetamine-like psychostimulants see section 4.5).
	Not to be used by patients taking beta-blockers (see section 4.5).
Paediatric Population
	Not to be used by children under 12 years of age.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&sect;&nbsp; Contains paracetamol.</p><p>&sect;&nbsp; Do not use with any other paracetamol-containing products. The concomitant use with other products containing paracetamol may lead to an overdose. Paracetamol overdose may cause liver failure which may lead to liver transplant or death.</p><p>&sect;&nbsp; Use with caution in patients with hepatic impairment or mild to moderate renal impairment.</p><p>&sect;&nbsp; Use with caution in patients with glutathione depletion due to metabolic deficiencies.</p><p>&sect;&nbsp; Use with caution in patients with psychosis.</p><p>&sect;&nbsp; Concomitant use of other cold and flu medicines should be avoided.</p><p>&sect;&nbsp; The hazard of overdose is greater in those with non-cirrhotic alcoholic liver disease.</p><p>&sect;&nbsp; Use with caution in patients with diabetes mellitus, arrhythmias or phaeochromocytoma.</p><p>&sect;&nbsp; Use with caution in patients taking antihypertensives or vasoconstrictive agents such as ergot alkaloids (see section 4.5 Interaction with other medicinal products and other forms of interaction).</p><p>&sect;&nbsp; Use with caution in patients over the age of 60 years. Patients in this age group are at greater risk of adverse reactions due to decreased renal function, and unwanted reactions when using oral sympathomimetic agents.</p><p>&sect;&nbsp; This product may give rise to insomnia and nervousness.</p><p>&sect;&nbsp; There have been reports of ischaemic colitis with pseudoephedrine. Pseudoephedrine should be discontinued immediately, and medical advice sought if sudden abdominal pain, rectal bleeding or other symptoms of ischaemic colitis develop.</p><p>&sect;&nbsp; There have been rare cases of posterior reversible encephalopathy (PRES) /reversible cerebral vasoconstriction syndrome (RCVS) reported with sympathomimetic drugs, including pseudoephedrine. Symptoms reported included sudden onset of severe headache, nausea, vomiting, and visual disturbances. Most cases improved or resolved within a few days following appropriate treatment. Pseudoephedrine should be discontinued immediately and medical advice sought if signs/ symptoms of PRES/RCVS develop.</p><p>&sect;&nbsp; Severe skin reactions such as acute generalized exanthematous pustulosis (AGEP) may occur with pseudoephedrine-containing products. This acute pustular eruption may occur within the first 2 days of treatment, with fever, and numerous, small, mostly non-follicular pustules arising on a widespread oedematous erythema and mainly localized on the skin folds, trunk, and upper extremities. Patients should be carefully monitored. If signs and symptoms such as pyrexia, erythema, or many small pustules are observed, administration of paracetamol/ pseudoephedrine caplets should be discontinued and appropriate measures taken if needed.</p><p>&sect;&nbsp; Ischaemic optic neuropathy. Cases of ischaemic optic neuropathy have been reported with pseudoephedrine. Pseudoephedrine should be discontinued if sudden loss of vision or decreased visual acuity such as scotoma occurs.</p><p>&sect;&nbsp; Care is advised in the administration of paracetamol/ pseudoephedrine caplet to patients who will be undergoing general anaesthesia. Acute perioperative hypertension may occur if volatile halogenated anaesthetics are used simultaneously with indirect sympathomimetic agents. It is recommended that pseudoephedrine treatment is stopped 24 hours before anaesthesia.</p><p>&sect;&nbsp; If you are taking medication, or are under medical care consult your doctor or pharmacist.</p><p>&sect;&nbsp; Pseudoephedrine content of this product may result in a positive reaction during antidoping control tests.</p><p>&sect;&nbsp; Caution is advised if paracetamol is administered concomitantly with flucloxacillin due to increased risk of high anion gap metabolic acidosis (HAGMA), particularly in patients with severe renal impairment, sepsis, malnutrition and other sources of glutathione deficiency (e.g. chronic alcoholism), as well as those using maximum daily doses of paracetamol. Close monitoring, including measurement of urinary 5- oxoproline, is recommended.</p><p>&sect;&nbsp; Keep all medicines safely out of sight and reach of children.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Pseudoephedrine hydrochloride </strong></p><p><strong>Risks of abuse </strong></p><p>As with other CNS stimulants, pseudoephedrine carries the risk of abuse. Increased doses may ultimately produce toxicity. Continuous use can lead to tolerance resulting in an increased risk of overdosing.</p><p><strong>Hepatotoxicity at therapeutic dose</strong></p><p>Cases of paracetamol induced hepatotoxicity, including fatal cases, have been reported in patients taking paracetamol at doses within the therapeutic range. These cases were reported in patients with one or more risk factors for hepatotoxicity including low body weight (&lt;50 kg), renal and hepatic impairment, chronic alcoholism, concomitant intake of hepatotoxic drugs and in acute and chronic malnutrition (low reserves of hepatic glutathione). Paracetamol should be</p><p>administered with caution to patients with these risk factors. Caution is also advised in patients on concomitant treatment with drugs that induce hepatic enzymes and in conditions which may predispose to glutathione deficiency (see section 4.2 and 4.9).</p><p>Doses of paracetamol should be reviewed at clinically appropriate intervals and patients should be monitored for emergence of new risk factors for hepatotoxicity, which may warrant dosage adjustment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The co-administration of paracetamol/ pseudoephedrine with tricyclic antidepressants, the antidepressant moclobemide decongestants, appetite suppressants and amphetamine like psychostimulants or with monoamine oxidase inhibitors (MAOI&rsquo;s) (or within two weeks of stopping MAOI&rsquo;s) which interfere with the catabolism of sympathomimetic agents, may occasionally cause a rise in blood pressure and may lead to hypertensive crisis in the case of moclobemide or MAOI&rsquo;s.</p><p>The oxazolidinone class of antibiotic (including furazolidone and linezolid) are known to cause a dose-related inhibition of monoamine oxidase. Therefore, they should not be taken with paracetamol/ pseudoephedrine as there is a potential to cause hypertensive crisis (see section 4.3).</p><p>Pseudoephedrine may antagonize the effect of certain classes of antihypertensives (e.g., beta-blockers, methyl-dopa, reserpine, debrisoquine, guanethidine) (see &nbsp;section 4.3 and 4.4).</p><p>Pseudoephedrine may interact with halogenated anaesthetics (see section 4.4).</p><p>Concomitant administration of vasoconstrictor agents (including ergot derivatives such as bromocriptine, pergolide, lisuride, cabergoline, ergotamine, dihydroergotamine and&nbsp; methylsergide) may cause an increased risk of ergotism (see section 4.4).</p><p>The rate of paracetamol absorption may be reduced by colestyramine. The interaction can be avoided by delaying administration of colestyramine by one hour, in order to maintain maximal analgesic effects.</p><p>The anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular daily use of paracetamol/ pseudoephedrine with increased risk of bleeding; occasional doses have no significant effect.</p><p>Sodium bicarbonate alkalinizes the urine and may reduce the renal elimination of pseudoephedrine, a reduction in dose may be necessary.</p><p>The speed of absorption of paracetamol may be increased by metoclopramide or domperidone.</p><p>Caution should be taken when paracetamol is used concomitantly with flucloxacillin as concurrent intake has been associated with high anion gap metabolic acidosis, especially in patients with risks factors (see section 4.4)</p><p>Phenytoin may reduce the analgesic and antipyretic effects of paracetamol and may increase the formation of the toxic N-acetyl-p-benzoquinone imine (NAPQI) metabolite of paracetamol leading to increased risk of hepatotoxicity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy:</u></strong></p><p>There are insufficient data from the use of the combination paracetamol and pseudoephedrine in pregnant women. Animal studies are insufficient with respect to reproductive toxicity. Epidemiological studies on neurodevelopment in children exposed to paracetamol in utero show inconclusive results. paracetamol/ pseudoephedrine is not recommended during pregnancy and in women of childbearing potential not using contraception.</p><p>&nbsp;</p><p><strong><u>Breastfeeding</u></strong></p><p>Pseudoephedrine is excreted in human milk to such an extent that effects on the breastfed newborns/infants are likely. paracetamol/ pseudoephedrine should not be used during breastfeeding.</p><p><strong><u>Fertility</u></strong></p><p>There are no relevant data available. See section 5.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dizziness is one of the most frequent adverse effects. This could affect driving or using machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse reactions are listed below by system organ class and frequency.</p><p>Frequencies are defined as: very common (&gt;1/10), common (&gt;1/100 and&lt;1/10), uncommon (&gt;1/1000 and &lt;1/100), rare (&gt;1/10,000 and &lt;1/1000) and very rare (&lt;1/10,000) and not known (cannot be estimated from the available date).</p><p>&nbsp;</p><p><strong><u>Paracetamol:</u></strong></p><p><strong><u>&nbsp;</u></strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class </strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reaction </strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic</p><p>system disorders</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Blood dyscrasia, including</p><p>thrombocytopenia and agranulocytosis</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Immune system</p><p>disorders</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypersensitivity*</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Anaphylaxis</p><p>Cutaneous hypersensitivity reactions</p><p>including, among others, Toxic Epidermal Necrolysis, Stevens Johnson syndrome, angioedema and skin rashes.</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hepatic dysfunction</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic</p><p>and mediastinal</p><p>disorders</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Bronchospasm is more likely in patients sensitive to aspirin or NSAIDs</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr></tbody></table><p>&nbsp;</p><p><strong><u>Pseudoephedrine:</u></strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class </strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reaction </strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr><tr><td rowspan="3"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Nervousness, insomnia</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Agitation, restlessness</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Hallucinations (particularly in children)</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Dizziness</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Headache, tremor</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Ischaemic optic neuropathy</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Dry mouth, nausea, vomiting</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Ischaemic colitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Skin and</p><p>subcutaneous</p><p>disorders</p></td><td style="vertical-align:top"><p>Allergic dermatitis*, rash</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Severe skin reactions, including acute</p><p>generalizes exanthematous pustulosis</p><p>(AGEP)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary</p><p>disorders</p></td><td style="vertical-align:top"><p>Urinary retention**</p><p>Dysuria</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Minor tachycardia</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Palpitations</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac arrhythmias</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Increased blood pressure</p></td><td style="vertical-align:top"><p>Rare</p></td></tr></tbody></table><p>&nbsp;</p><p>*A variety of allergic skin reactions, with or without systemic features such as<br />&nbsp; bronchospasm, angioedema have been reported following use of pseudoephedrine.</p><p>**Urinary retention is most likely to occur in those with bladder outlet obstruction such<br />&nbsp;&nbsp;&nbsp; as prostatic hypertrophy.</p><p>&nbsp;</p><p><strong><u>To report any side effect(s):</u></strong></p><p>&sect; <strong>Saudi Arabia:</strong></p><p><strong>The National Pharmacovigilance Centre (NPC):</strong></p><p><strong>- Fax:</strong> +966-11-205-7662</p><p><strong>- SFDA Call Centre: </strong>19999</p><p><strong>- E-mail: </strong>npc.drug@sfda.gov.sa</p><p><strong>- Website: </strong>https://ade.sfda.gov.sa</p><p>&sect; <strong>Other GCC States:</strong></p><p><strong>- </strong>Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Paracetamol</u></strong></p><p>Liver damage is likely in patients who have taken more than the recommended amounts of paracetamol. It is considered that excess quantities of toxic metabolite become irreversibly bound to liver tissue. Some patients may be at increased risk of liver damage from paracetamol toxicity.</p><p>Risk factors: If the patient:</p><p>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Is on long term treatment with carbamazepine, phenobarbitone, phenytoin, primidone, rifampicin, St John&rsquo;s Wort or other drugs that induce liver enzymes.</p><p>Or</p><p>b.&nbsp;&nbsp;&nbsp;&nbsp; Regularly consumes ethanol in excess of recommended amounts.</p><p>Or</p><p>c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Is likely to be glutathione deplete e.g. eating disorders, cystic fibrosis, HIV infection, starvation, cachexia.</p><p><strong>Symptoms</strong></p><p>Paracetamol overdose may cause liver failure, which may lead to liver transplant and death.</p><p>Symptoms of paracetamol overdose usually occur within the first 24 hours and are pallor, nausea, vomiting, anorexia and abdominal pain.</p><p>Simultaneously, increased levels of hepatic transaminases (AST, ALT), lactate dehydrogenase and bilirubin are observed together with increased prothrombin time that may appear 12 to 48 hours after administration. Abnormalities of glucose metabolism and metabolic acidosis may occur. Clinical symptoms of liver damage are usually evident initially after 2 days, and reach a maximum after 4 to 6 days.</p><p>Acute renal failure with acute tubular necrosis, strongly suggested by loin pain, haematuria and proteinuria, may develop, even in the absence of severe liver damage. Other non-hepatic symptoms that have been reported following paracetamol overdosage include myocardial abnormalities and pancreatitis.</p><p>In severe poisoning, hepatic failure may progress to encephalopathy, haemorrhage, hypoglycaemia, cerebral oedema, and death.</p><p><strong>Management</strong></p><p>Immediate treatment is essential in the management of paracetamol overdose.</p><p>Despite a lack of significant early symptoms, patients should be referred to hospital urgently for immediate medical attention. Symptoms may be limited to nausea or vomiting and may not reflect the severity of overdose or the risk of organ damage. Management should be in accordance with established treatment guidelines.</p><p>Paracetamol concentrations in blood should be measured not less than 4 hours after overdose in order to be able to assess the risk of developing liver damage (using the paracetamol overdose nomogram). However, N-acetylcysteine (NAC) treatment should be started immediately when massive overdose is suspected.</p><p>The administration of activated charcoal may be beneficial when performed within one hour of the overdose but can be considered for up to four hours after the overdose.</p><p>Intravenous (IV) infusion (or oral administration if IV infusion is not possible) of the antidote N-acetylcysteine should be started if possible before the 8<sup>th</sup> hour. The effectiveness of the antidote declines sharply after this time. Nacetylcysteine can, however, give some degree of protection even after 8 hours, and up to 24 hours, but in these cases prolonged treatment is given. If vomiting is not a problem, oral methionine may be a suitable alternative for remote areas, outside hospital.</p><p>Symptomatic treatment should be implemented.</p><p><strong><u>Pseudoephedrine</u></strong></p><p><strong>Symptoms</strong></p><p>As with other sympathomimetics pseudoephedrine overdose will result in symptoms due to central nervous system and cardiovascular stimulation e.g. excitement, irritability, restlessness, tremor, hallucinations, hypertension, palpitations, arrhythmias and difficulty with micturition. In severe cases, psychosis, convulsions, coma and hypertensive crisis may occur. Serum potassium levels may be low due to extracellular to intracellular shifts in potassium.</p><p><strong>Management</strong></p><p>Treatment should consist of standard supportive measures. Beta-blockers should reverse the cardiovascular complications and the hypokalaemia.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC Code N02B E51</p><p><strong>Adol sinus</strong> is a mild to moderate analgesic, antipyretic and decongestant.</p><p>Mechanism of action</p><p>The analgesic and antipyretic actions of paracetamol are believed to be due, at least in part, to inhibition of prostaglandin synthesis in the central nervous system.</p><p>Pseudoephedrine acts on the alpha adrenergic receptors in the mucosa of the respiratory tract producing vasoconstriction which results is shrinkage of swollen nasal mucous membranes, reduction of nasal congestion and increase in nasal airway patency.</p><p>Pharmacodynamic effects</p><p><em>Paracetamol</em> is an analgesic and antipyretic.</p><p><em>Pseudoephedrine</em> is a nasal decongestant.</p><p>Clinical efficacy and safety</p><p>Paracetamol<em> 1 g </em>has been shown to be an effective analgesic and antipyretic.</p><p><em>Pseudoephedrine 60mg</em> has been shown to be an effective nasal decongestant, as measured by nasal airflow, in patients with the common cold and rhinitis.</p><p>At therapeutic doses, pseudoephedrine has no clinically significant effect on blood pressure in normotensive patients. Studies in patients with controlled hypertension have demonstrated that pseudoephedrine 60mg has no, or minimal, effect on blood pressure and does not have sedative effects.</p><p>A clinical study has been conducted in patients with symptoms of cold and flu to assess relief of pain and nasal congestion. The study compared paracetamol/ pseudoephedrine (taken three times daily as required for three days) with paracetamol alone, pseudoephedrine alone and placebo. Results demonstrated that paracetamol/ pseudoephedrine gives significantly (p&lt;0.05) greater pain relief than either placebo or pseudoephedrine and that paracetamol/ pseudoephedrine has a significantly (p&lt;0.05) greater decongestant effect than either placebo or paracetamol. Paracetamol/ pseudoephedrine demonstrated an additive effect for relief of pain and nasal congestion compared to paracetamol or pseudoephedrine.</p><p>For a single dose of paracetamol/ pseudoephedrine there was significantly greater (P&lt;0.05) relief of pain and nasal congestion (nasal airflow) compared to placebo at one hour post dose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Paracetamol:</u></strong></p><p><strong>Absorption: </strong>The absorption of paracetamol by the oral route is rapid and complete. Maximum plasma concentrations are reached 30 to 60 minutes following ingestion.</p><p><strong>Distribution: </strong>Paracetamol is distributed rapidly throughout all tissues. Concentrations are comparable in blood saliva and plasma. Protein binding is low.</p><p><strong>Metabolism: </strong>Paracetamol is metabolised mainly in the liver, following two major metabolic pathways: Glucuronic acid and sulfuric acid conjugates. The latter route is rapidly saturated at doses higher than the therapeutic dosages. A minor route, catalyzed by the Cytocrome P 450 (mostly CYP2E1), results in the formation of an intermediate reagent (N-acetyl-p-benzoquinoneimine) which under normal conditions of use, is rapidly detoxified by glutathione and eliminated in the urine, after conjugation with cysteine and mercapturic acid.</p><p>Conversely, when massive intoxication occurs, the quantity of this toxic metabolite is increased.</p><p><strong>Elimination: </strong>Elimination is essentially through the urine. 90% of the ingested dose is eliminated via the kidneys within 24 hours, principally as glucuronide (60-80%) and sulphate conjugates (20-30%). Less than 5% is eliminated in unchanged form.</p><p>Elimination half-life is about 2 hours.</p><p><em>Physiopathological variations</em></p><p><strong>Renal Insufficiency: </strong>In cases of severe renal insufficiency (creatinine clearance lower than 10ml/min) the elimination of paracetamol and its metabolites is delayed.</p><p><strong>Elderly subjects: </strong>Conjugation capacity is not modified.</p><p><strong><u>Pseudoephedrine:</u></strong></p><p><strong>Absorption: </strong>Pseudoephedrine is rapidly and completely absorbed from the gastrointestinal tract after oral administration with no presystemic metabolism.</p><p>Peak plasma levels are achieved after 1-2 hours.</p><p><strong>Distribution: </strong>Pseudoephedrine is rapidly distributed throughout the body. No protein binding data are available. The volume of distribution ranges from 2.64 to 3.51 l/kg in both single and multiple dose studies.</p><p><strong>Metabolism: </strong>There is little metabolism of pseudoephedrine in man with approximately 90% being excreted in the urine unchanged. Approximately 1% is eliminated by hepatic metabolism, by N-demethylation to norpseudoephedrine.</p><p><strong>Elimination: </strong>The plasma half-life varies from 4.3-7.0 hours in adults. As a weak base the extent of renal excretion is dependent on urinary pH. At low pH tubular resorption is minimal and urine flow rate will not influence clearance of the drug. At high pH (&gt;7.0) pseudoephedrine is extensively reabsorbed in the renal tubule and renal clearance will depend on urine flow rate.</p><p><em>Physiopathological variations</em></p><p><strong>Renal Insufficiency: </strong>Renal impairment will result in increased plasma levels.</p><p><strong>Elderly subjects: </strong>Elimination capacity is not modified.</p><p>A steady state pharmacokinetic interaction study in healthy volunteers has demonstrated that the rate (Cmax, tmax) and extent (AUC0-6 hours) of absorption from paracetamol/ pseudoephedrine is equivalent to those of paracetamol alone and of pseudoephedrine alone.</p><p>In the same study the median tmax values for the paracetamol and pseudoephedrine components were 0.7 hours and 1.2 hours, respectively.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no preclinical data considered relevant to clinical safety beyond data included in other sections of the SPC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:528px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Inactive ingredients:</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>1.&nbsp;&nbsp;&nbsp;&nbsp; Maize starch</p></td></tr><tr><td style="vertical-align:top"><p>2.&nbsp;&nbsp;&nbsp;&nbsp; Povidone</p></td></tr><tr><td style="vertical-align:top"><p>3.&nbsp;&nbsp;&nbsp;&nbsp; Microcrystalline cellulose</p></td></tr><tr><td style="vertical-align:top"><p>4.&nbsp;&nbsp;&nbsp;&nbsp; Cellulose powder</p></td></tr><tr><td style="vertical-align:top"><p>5.&nbsp;&nbsp;&nbsp;&nbsp; Primojel</p></td></tr><tr><td style="vertical-align:top"><p>6.&nbsp;&nbsp;&nbsp;&nbsp; Stearic acid fine powder</p></td></tr><tr><td style="vertical-align:top"><p>7.&nbsp;&nbsp;&nbsp;&nbsp; Talc fine powder</p></td></tr><tr><td style="vertical-align:top"><p>8.&nbsp;&nbsp;&nbsp;&nbsp; Magnesium stearate</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Coating materials: </u></strong></p></td></tr><tr><td style="vertical-align:top"><p>1.&nbsp;&nbsp;&nbsp;&nbsp; Hypromellose</p></td></tr><tr><td style="vertical-align:top"><p>2.&nbsp;&nbsp;&nbsp;&nbsp; Talc fine powder</p></td></tr><tr><td style="vertical-align:top"><p>3.&nbsp;&nbsp;&nbsp;&nbsp; Polyethylene glycol</p></td></tr><tr><td style="vertical-align:top"><p>4.&nbsp;&nbsp;&nbsp;&nbsp; Titanium dioxide</p></td></tr><tr><td style="vertical-align:top"><p>5.&nbsp;&nbsp;&nbsp;&nbsp; FD&amp;C blue no. 1 lake</p></td></tr><tr><td style="vertical-align:top"><p>6.&nbsp;&nbsp;&nbsp;&nbsp; D&amp;C yellow no. 10 lake</p></td></tr><tr><td style="vertical-align:top"><p>7.&nbsp;&nbsp;&nbsp;&nbsp; Opadry- OY-S 29019 clear</p></td></tr><tr><td style="vertical-align:top"><p>8.&nbsp;&nbsp;&nbsp;&nbsp; Purified water</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months from the date of manufacturing.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&ordm;C, in a dry place, in the original container.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>2 x 12&rsquo;s caplets blister strip, packed in a printed carton along with a leaflet.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street.
Ras Al Khaimah - United Arab Emirates.
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                30. November. 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>